Avrum Froimson, M.D.
| Appointed: |
1998 |
| Gender: |
Male |
| Languages: |
English |
Orthopaedic Surgery (Beachwood)
Professional Highlights
- Founder and Chief Hand Surgery Clinic MetroGeneralHospital, 1962-1980
- Chairman of Orthopaedics Mt Sinai,1980-1997
- Offers In Clinic/Office Needle Aponeurotomy for Dupuytren's Contracture
Education & Fellowships
| Medical School: | Tulane University School of Medicine, New Orleans, LA |
|
| Internship: | Philadelphia General Hospital (closed), General Surgery, Philadelphia, PA |
| Residency: | Saint Luke's Medical Center, Radiology, Cleveland, OH |
| Residency: | Saint Luke's Medical Center, Orthopaedic Surgery, Cleveland, OH |
| Fellowship: | New York Presbyterian Hospital, Columbia Presbyterian Campus, Hand Surgery, New York, NY |
| Other Education: | (Undergraduate) Case Western Reserve University, Cleveland, OH |
Additional Training
- Needle Aponeurotomy for Dupuytren' Contracture
Certifications
Surgery of the Hand
Orthopaedic Surgery
Specialty Interests
Fractures, hand, hand and wrist arthritis, hand injuries, hand related sports injuries, hand surgery, needle aponeurotomy for Dupuytren's Disease, surgery of the hand and wrist, wrist and elbow.
Innovations & Patents
- Patent: 1974 #3,789,842. The Froimson Tennis Elbow Support; used worldwide in the treatment of tennis elbow
- Invented/published novel surgical procedures for thumb arthritis, trigger finger, biceps tendon rupture, elbow arthritis, wrist tendinitis
Awards & Honors
- Mt Sinai Teaching Excellence Award
- "Best Docs" Cleveland Magazine, 1996-2004
- Best Doctors in USA Midwest Region,1997
Professional Memberships
- American Orthopaedic Association
- American Academy of Orthopaedic Surgeons
- American Society for Surgery of the Hand
- Past president, American Foundation for Surgery of the Hand
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/29/2009 the review process regarding Dr. Froimson’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
